An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015

"Background: A quadrivalent human papillomavirus (HPV4) type 6/11/16/18 vaccine (GARDASIL/SILGARD®) has been licensed in many countries around the world for the prevention of cervical, vulvar, vaginal, and anal cancers and precancers, as well as external genital warts causally related to HPV ty...

Descripción completa

Detalles Bibliográficos
Autores Principales: Vichnin, Michelle, Bonanni, Paolo, Klein, Nicola P., Garland, Suzanne M., Block, Stan L., Kjaer, Susanne K., Sings, Heather L., Perez, Gonzalo, Haupt, Richard M., Saah, Alfred J., Lievano, Fabio, Velicer, Christine, Drury, Rosybel, Kuter, Barbara J.
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: Lippincott Williams and Wilkins 2015
Materias:
Acceso en línea:https://repository.urosario.edu.co/handle/10336/22776
https://doi.org/10.1097/INF.0000000000000793